Citius Oncology (CTOR) Payables (2023 - 2026)
Citius Oncology (CTOR) posted quarterly Payables of $6.0 million for Q1 2026, down 47.72% year-over-year from $11.5 million in Q1 2025, and down 7.69% quarter-over-quarter from $6.5 million in Q4 2025.
Citius Oncology (CTOR) Payables (2023 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported Payables for 4 consecutive years, with $6.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Payables fell 47.72% year-over-year to $6.0 million; the TTM figure through Mar 2026 stood at $6.0 million (down 47.72% YoY), while the FY2025 annual figure was $17.0 million, up 126.78% from the prior year.
- Payables declined to $6.0 million in Q1 2026 per CTOR's latest filing, from $6.5 million in the prior quarter.
- Across five years, Payables topped out at $17.0 million in Q3 2025 and bottomed at $1.3 million in Q3 2023.
- Historically, Payables has averaged $7.0 million across 4 years, with a median of $6.5 million in 2025.
- Annual changes were most pronounced in 2025 — Payables jumped 655.03% — and 2026, when it slumped 47.72%.
- Citius Oncology's Payables stood at $1.3 million in 2023, then jumped by 632.93% to $9.7 million in 2024, then slumped by 32.81% to $6.5 million in 2025, then fell by 7.69% to $6.0 million in 2026.
- Business Quant data shows CTOR's Payables at $6.0 million in Q1 2026, $6.5 million in Q4 2025, and $17.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -7.73 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 986.00 Mn |
| 10 | Citius Oncology | 80.25 Mn | 80.25 Mn | 1.00 Mn | 7.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.00 Mn |
| Dec 31, 2025 | 6.50 Mn |
| Sep 30, 2025 | 17.03 Mn |
| Jun 30, 2025 | 12.47 Mn |
| Mar 31, 2025 | 11.48 Mn |
| Dec 31, 2024 | 9.67 Mn |
| Sep 30, 2024 | 7.51 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Mar 31, 2024 | 1.52 Mn |
| Dec 31, 2023 | 1.32 Mn |
| Sep 30, 2023 | 1.29 Mn |